Novita Healthcare Limited

Status: Registered
Current name since: November 30, 2016
Name in the ASICs register: Novita Healthcare Limited
Australian Company Number: 108150750
Australian Business Number: 53108150750
Registration date: April 7, 2004
Type: Australian public company
Class: Limited by Shares
Subclass: Listed public company
last updated

Description

Novita Healthcare Limited is a limited by shares, listed public company, Australian public company. This corporation was registered on 2004-04-07 and was issued with the 108150750 ACN. Its Australian Business Number is 53108150750. Since 2020-05-08, the company is headquartered in VIC, post code 3121. The previous headquarters were located in VIC 3123 (from 2016-04-19 to 2020-05-08), VIC 3121 (from 2014-09-22 to 2016-04-19), and VIC 3121 (from 2014-01-16 to 2014-09-22). Novita Healthcare Limited was registered for the GST on 2004-07-01. Novita Healthcare Limited has been using the Avexa Limited trading name since 2004-09-09 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 2 trading names. The company has also used 1 business name, namely Tali Digital from 2019-10-21 to 2023-08-17. The above data comes from the ABN database which was updated on 2023-08-17. We found 3 trademarks that mention this company. Trademark number 1086576 was filed on 2005-11-18 and is categorised as "word" (application status: "registered, live"). Other company trademarks include trademark number 1088656 registered on 2005-12-02 in the "word" category (application status/date: "registered, live", 2005-12-02); and trademark number 1088691 registered on 2005-12-02 in the "composite" category (application status/date: "registered, live", 2005-12-02).

Details for ABN 53108150750

Type: Australian Public Company

ABN Status

Status From To
Active July 1, 2004 current

Main Name

Name From To
Tali Digital Limited December 5, 2019 current
Novita Healthcare Limited December 3, 2016 December 5, 2019
Novita Healthcare Ltd December 1, 2016 December 3, 2016
Avexa Limited July 1, 2004 December 1, 2016

Business Names

Name From To
Tali Digital October 21, 2019 August 17, 2023

Trading Names

Name From To
Avexa Limited September 9, 2004 current
Avexa Limited July 1, 2004 September 9, 2004

Main Location

Location From To
VIC 3121 May 8, 2020 current
VIC 3123 April 19, 2016 May 8, 2020
VIC 3121 September 22, 2014 April 19, 2016
VIC 3121 January 16, 2014 September 22, 2014
VIC 3121 July 10, 2005 January 16, 2014
VIC 3121 July 1, 2004 July 10, 2005

Goods & Services Tax (GST)

Status From To
Registered July 1, 2004 current

Advertisements

Company Trademarks

Trademark number: 1086576

General information:
Application date: November 18, 2005
Lodgement date: November 18, 2005
Registered date: November 18, 2005
Live or dead: Live
CPI status: Registered
Status: Registered/Protected - Renewal Due
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: March 2, 2006
Sealing due date: January 7, 2007
Registered from date: November 18, 2005
Sealing date: December 11, 2006
Renewal due date: November 18, 2015
Court orders: No
Revocation of the acceptance: No
Lodgement type: National
Descriptive: Avexite
Examination report number: 1
Examination class count: 1
NICE class code: 5
NICE occ number: 1
NICE description text: Pharmaceutical Preparations And Substances
Applicant information:
Suburb name: Malvern
Postcode: 3144
Australian state code: VIC
Country code: AU
Attorney information:
Attorney code: -86797
Agency code: DM
Transaction type: Address for service of the trademark
Suburb name: Melbourne
Postcode: 3000
Australian state codee: VIC
Attorney type: Attorney
Country code: AU
Oppositions and Hearings:
Status code: 99
Type: Opposition
Code: ST
Notice of Opposition lodged on: June 5, 2006
Extension date to lodge Evidence in Support: December 5, 2006
Application withdrawal date: December 1, 2006
Trade Marks act year: 1995
Status of the opposition: Finalised
Opposition record created on: June 23, 2006
Opposition record modified on: March 2, 2013
Opposition status data: Notice of Opposition|Due: 16-JUN-2006 |Lodged: 05-JUN-2006

Trademark number: 1088656

General information:
Application date: December 2, 2005
Lodgement date: December 2, 2005
Registered date: December 2, 2005
Live or dead: Live
CPI status: Registered
Status: Registered/Protected - Renewal Due
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: February 20, 2007
Sealing due date: March 18, 2010
Registered from date: December 2, 2005
Sealing date: December 21, 2009
Renewal due date: December 2, 2015
Court orders: No
Revocation of the acceptance: No
Lodgement type: Online
Descriptive: Avexa
Examination report number: 2
Examination class count: 4
NICE class code: 44
NICE occ number: 1
NICE description text: Medical Services, Healthcare Services; Advisory Services Relating To Healthcare
Applicant information:
Suburb name: Richmond
Postcode: 3121
Australian state code: VIC
Country code: AU
Attorney information:
Attorney code: -86797
Agency code: DM
Transaction type: Address for service of the trademark
Suburb name: Melbourne
Postcode: 3000
Australian state codee: VIC
Attorney type: Attorney
Country code: AU
Oppositions and Hearings:
Status code: 99
Type: Opposition
Code: ST
Notice of Opposition lodged on: May 11, 2007
Extension date to lodge Evidence in Support: March 11, 2008
Evidence in Support lodged on: March 12, 2008
Evidence in Support served on: March 11, 2008
Evidence in Support type: Balance
Extension date to lodge Evidence in Answer: December 11, 2008
Evidence in Answer lodged on: December 4, 2008
Evidence in Answer served on: December 3, 2008
Evidence in Answer type: All
Extension date to lodge Evidence in Reply: April 3, 2009
Evidence in Reply lodged on: March 27, 2009
Evidence in Reply served on: March 31, 2009
Evidence in Reply type: All
Application withdrawal date: October 28, 2009
Trade Marks act year: 1995
Status of the opposition: Finalised
Opposition record created on: May 16, 2007
Opposition record modified on: March 2, 2013
Opposition status data: Notice of Opposition|Due: 08-JUN-2007 |Lodged: 11-MAY-2007

Trademark number: 1088691

General information:
Application date: December 2, 2005
Lodgement date: December 2, 2005
Registered date: December 2, 2005
Live or dead: Live
CPI status: Registered
Status: Registered/Protected - Renewal Due
Mark code: Trade Mark
Trademark type: Composite
Acceptance due date: March 16, 2006
Sealing due date: April 7, 2007
Registered from date: December 2, 2005
Sealing date: March 23, 2007
Renewal due date: December 2, 2015
Court orders: No
Revocation of the acceptance: No
Lodgement type: Online
Descriptive: Avexa
Device phrases: Polygon,prism,extended
Examination report number: 1
Examination class count: 4
NICE class code: 44
NICE occ number: 1
NICE description text: Medical Services, Healthcare Services; Advisory Services Relating To Healthcare
Applicant information:
Suburb name: Richmond
Postcode: 3121
Australian state code: VIC
Country code: AU
Attorney information:
Attorney code: 489124
Agency code: SF
Transaction type: Opponent agent code in opposition
Suburb name: Sydney
Postcode: 2001
Australian state codee: NSW
Attorney type: Attorney
Country code: AU
Oppositions and Hearings:
Status code: 99
Type: Opposition
Code: ST
Notice of Opposition lodged on: June 30, 2006
Extension date to lodge Evidence in Support: December 30, 2006
Application withdrawal date: December 18, 2006
Trade Marks act year: 1995
Status of the opposition: Finalised
Opposition record created on: July 6, 2006
Opposition record modified on: March 20, 2015
Opposition status data: Notice of Opposition|Due: 30-JUN-2006 |Lodged: 30-JUN-2006

Company Patents

Patent Application Number: 2009266421

General information:

Application date: December 21, 2010
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: NPE
Primary IPC mark: C07D 471/04
WIPO Application Number: WO2010/000032
Original WIPO Application Number: WO10/00032
PCT Application Number: PCT/AU2009/000858
Original PCT Application Number: PCT/AU09/00858
Accepted claims count: 22

International Patent Classification:

IPC Mark: A61P 31/18
Version date of the IPC Classification record: January 1, 2006
Section code: A - human necessities
Class code: 61 - medical or veterinary science; hygiene
Subclass code: P - specific therapeutic activity of chemical compounds or medicinal preparations
Main group code: 31 - antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Subgroup code: 18 - for hiv
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: January 7, 2010
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request date: October 25, 2011
Examination request filing date: March 28, 2012
Requested examination type: Request Full Examination
First report issue date: March 8, 2013
Examination section: A5 MPEC
Expiry date: July 2, 2029
Earliest priority date: July 2, 2008
Acceptance Notice date: July 11, 2013
Sealing date: October 24, 2013
WIPO publication date: January 7, 2010
Effective patent date: July 2, 2009
Continue renew fee paid date: June 30, 2014
Patent in force to: July 2, 2015

Patent Application Number: 2010201160

General information:

Application date: March 24, 2010
Patent status: Lapsed

Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months).

Patent type: STANDARD
Primary IPC mark: C07D 239/70

International Patent Classification:

IPC Mark: C07D 277/60
Version date of the IPC Classification record: January 1, 2006
Section code: C - chemistrymetallurgy
Class code: 7 - organic chemistry
Subclass code: D - heterocyclic compounds (macromolecular compounds c08)
Main group code: 277 - heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Subgroup code: 60 - condensed with carbocyclic rings or ring systems
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: March 31, 2010
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: March 25, 2010
Requested examination type: Request Full Examination
First report issue date: March 9, 2011
Examination section: C2 Chemistry
Expiry date: December 21, 2027
Earliest priority date: December 22, 2006
Effective patent date: December 21, 2007
OPI published in journal date: April 15, 2010
Patent in force to: December 21, 2012

Early terminations:

Application status: Lapsed
Applied date: December 10, 2012
Reason description: Did Not Gain Acceptance Within The Prescribed Time.
Published date: January 10, 2013

Patent Application Number: 2008303073

General information:

Application date: March 30, 2010
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: NPE
Primary IPC mark: C07D 411/04
WIPO Application Number: WO2009/039582
Original WIPO Application Number: WO09/39582
PCT Application Number: PCT/AU2008/001433
Original PCT Application Number: PCT/AU08/01433
Accepted claims count: 20

International Patent Classification:

IPC Mark: C07D 411/04
Version date of the IPC Classification record: January 1, 2006
Section code: C - chemistrymetallurgy
Class code: 7 - organic chemistry
Subclass code: D - heterocyclic compounds (macromolecular compounds c08)
Main group code: 411 - heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
Subgroup code: 4 - directly linked by a ring-member-to-ring- member bond
Mark type: First (ie Primary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: April 2, 2009
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request date: July 25, 2011
Examination request filing date: September 28, 2011
Requested examination type: Request Full Examination
First report issue date: May 4, 2012
Examination section: C2 Chemistry
Expiry date: September 26, 2028
Earliest priority date: September 28, 2007
Acceptance Notice date: August 9, 2012
Sealing date: November 22, 2012
WIPO publication date: April 2, 2009
Effective patent date: September 26, 2008
Continue renew fee paid date: August 26, 2014
Patent in force to: September 26, 2015

Find company

VIC 3121 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.